LoneSilverWolf said
BUT, it has worked before, magnum. They have used it on OTHER people in the past, who are in a similar situation as he was. They stand to gain another success story if it works, and judging by the prior evidence, it will. We're not talking about something that's never been used, or that has been shown to kill half the people it's given too. So I'd say there's a lot more to be gained then lost here.
It issue is it's not confirmed to be safe enough yet though to be given out to the public like that.
That's why it's still under testing, the risk is still there.
Now note, I understand the concept of going with something not fully in yet and rolling the dice.
My Mom did the same with ABA Therapy when I was diagnosed with Autism (It was simply a small University study atm) and it worked.
I know this kind of stuff can work.
The issue is this one plays with people's lives, in the sense that people could live or die depending on the actions taken.
You're right that in this case (at least from the info we have) odds are in favor of it working.
But if it doesn't, the results could be terrible.
Personally, assuming there aren't any other medical concerns the company has that the media isn't shedding light on I would support getting the child the medication, and if it does go bad take note of it and use it to help improve the product before others take it. But I understand the legal concerns, where they may not even have the chance to give said medication to others if giving it to the child does in fact turn out bad or simply fails to help him.
